(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-dideoxy-3-(dimethylamino)-β-d-glucopyranosyl]oxy]-4-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-β-d-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-dien-2-one (neospiramycin I),; Neo Spiramycin I
Spiramycin EP Impurity A (Neospiramycin I) is a fully characterized chemical compound used as a reference standard of API Spiramycin. The standard offered is compliant with regulatory guidelines. Spiramycin EP Impurity A (Neospiramycin I) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 70253-62-2
